Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Evaluation of Muscle Performance and Cardiopulmonary Fitness in Patients with Multiple SclerosisImplications for Rehabilitation.
Gray Matters in Multiple Sclerosis: Cognitive Impairment and Structural MRI.
SOCS signaling in autoimmune diseases: molecular mechanisms and therapeutic implications.
Dextromethorphan/Quinidine for the treatment of pseudobulbar affect.
Proteome analysis of post-transplantation recovery mechanisms of an EAE model of multiple sclerosis treated with embryonic stem cell-derived neural precursors.
Premature immune senescence in children with MS: Too young to go steady.
Parasite Infections in Multiple Sclerosis Modulate Immune Responses through a Retinoic Acid-Dependent Pathway.
Deep brain stimulation for pain.
Visual issues in multiple sclerosis.
Evasion of Antiviral Innate Immunity by Theiler's Virus L* Protein through Direct Inhibition of RNase L.
Idiopathic acute transverse myelitis: Complete recovery after intravenous immunoglobulin.
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) in humans with multiple sclerosis.
Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.
FOXP3, CBLB and ITCH gene expression and cytotoxic T lymphocyte antigen 4 expression on CD4(+) CD25(high) T cells in multiple sclerosis.
Axonal selection and myelin sheath generation in the central nervous system.
Retrograde retinal damage after acute optic tract lesion in MS.
IL-22 secreting CD4+ T cells in the patients with neuromyelitis optica and multiple sclerosis.
Erratum to: Advancing drug delivery systems for the treatment of multiple sclerosis.
Role of socioeconomic position in multiple sclerosis etiology.
Elevated Phospholipid Transfer Protein in Subjects with Multiple Sclerosis.
Modulation of Immune response by Ultra-violet light in HLA class-II transgenic mice.
Best Practices for Network Meta-Analysis Methodology: Comparative Effectiveness of Interferon-Beta Therapies In Relapsing-Remitting Multiple Sclerosis.
Immunopathology of multiple sclerosis.
Quantitative PCR Analysis of DNA Aptamer Pharmacokinetics in Mice.
Diagnosis and quantification of cognitive fatigue in multiple sclerosis.
Pages
« first
‹ previous
…
553
554
555
556
557
558
559
560
561
…
next ›
last »